Aug 21 |
Companies Like Vincerx Pharma (NASDAQ:VINC) Could Be Quite Risky
|
Aug 9 |
Vincerx Pharma GAAP EPS of -$0.05
|
Aug 8 |
Vincerx Pharma Reports Second Quarter 2024 Financial Results
|
Jun 27 |
Vincerx Pharma (VINC) Moves to Buy: Rationale Behind the Upgrade
|
May 15 |
Vincerx Pharma GAAP EPS of -$0.58
|
May 14 |
Vincerx Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
|
Apr 26 |
Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
|
Apr 26 |
Vincerx Pharma dips 16%, prices $16M stock
|
Apr 26 |
Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and Warrants
|
Apr 25 |
Vincerx Pharma announces proposed underwritten public offering of common stock and warrants
|